Doctor examining a patient with a stethoscope

Our purpose is to reimagine medicine to improve and extend people's lives.

Scientist working in a lab

Our vision is to become the most valued and trusted medicines company in the world.

Scientist working on a computer

Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Focus Areas

To support this strategy, we have clear focus areas and priorities to create value for our company, our shareholders and society.

Therapeutic Areas

Our focus is in 5 core therapeutic areas:
  • Cardiovascular
  • Immunology
  • Neuroscience
  • Solid Tumors
  • Hematology

These areas have significant disease burden.

Business people in a meeting room looking at a screen displaying a 3D heart

 

Technology Platforms

Our technology platform areas are:
  • Chemistry
  • Biotherapeutics
  • xRNA
  • Radioligand
  • Gene and cell therapy

We have the depth and scale to discover, develop and commercialize therapies.

CAR-T cells attacking cancerous B-cells

 

Strategic Priorities

These focus areas are supported by strategic priorities, which determine how we implement our strategy.

Growth icon

Deliver high-value medicines to accelerate growth.

Gear icon

Embed operational excellence to deliver returns.

Stakeholders hands icon

Strengthen our foundations by:

  • Unleashing the power of our people
  • Scaling data science and technology
  • Building trust with society

Related Content

Cover of the 2022 Novartis in Society Integrated Report, Van Lacour, prostate cancer patient living in Natchez, Louisiana, who received a Novartis radioligand therapy

Novartis in Society Integrated Report 2022

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders.
Close up of a hand holding a lab sample

Innovative Medicines

Transformation to a pure-play innovative medicines company.
HCP discussing with patients in Africa

Environmental, Social and Governance

At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues.